This focused issue on “Predictive and Prognostic Biomarkers in Tumors” is edited by Dr. Mari Mino-Kenudson, from Department of Pathology, Massachusetts General Hospital, Boston, MA, USA; and Dr. Yin (Rex) P. Hung, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Dr. Mari Mino-Kenudson was trained as a Pulmonary Medicine resident and fellow after graduating from Kyoto University, Faculty of Medicine, Kyoto, Japan, and worked as a staff Pulmonologist at Tenri Hospital, Nara, Japan for several years. Then, she changed her career from Pulmonary Medicine to Pathology. After completing Pathology residency and fellowship, she came on staff at Department of Pathology, at MGH in 2004. She has been conducting translational research on lung cancer in collaboration with molecular pathologists, thoracic oncologists, thoracic surgeons and basic scientists.
Dr. Yin (Rex) P. Hung is a diagnostic specialist in pulmonary, cardiovascular, and bone and soft tissue pathology at Massachusetts General Hospital. His clinical practice and research focus include mesothelioma, lung cancer, and sarcomas.
Focused issue outline:
- Preface to this focused issue
Mari Mino-Kenudson and Yin (Rex) P. Hung, Department of Pathology, Massachusetts General Hospital, Boston, MA, USA - Lung cancer
Yin (Rex) P. Hung and Mari Mino-Kenudson, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA - Head and neck tumors
Sara Pai, Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA - Skin tumors
Rosalynn Nazarian, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA - Brain tumors
Wesley Samore, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Maria Martinez-Lage, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, USA - Microsatellite instability
Elizabeth Wu and Murray Resnick, Department of Pathology, Rhode Island Hospital and Lifespan Medical Center, Providence, RI, USA - NTRK alterations
Yin (Rex) P. Hung, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
Anna Farago, Massachusetts General Hospital, Cancer Center and Department of Medicine, Boston, MA, USA - BRAF alterations
Lynette Sholl, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA - Biomarkers of checkpoint inhibitors
Mari Mino-kenudson, Department of Pathology, Massachusetts General Hospital, Boston, MA, USA
Disclosure:
The series “Predictive and Prognostic Biomarkers in Tumors” was commissioned by the editorial office, Precision Cancer Medicine without any sponsorship or funding. Mari Mino-Kenudson and Yin (Rex) P. Hung are serving as the unpaid Guest Editors for the series.
